Cleerly is a healthcare technology company which offers AI-based digital care platforms designed for the evaluation and treatment of heart disease to healthcare providers. Their platform analyzes coronary computed tomography angiography (CCTA) imaging to identify and quantify atherosclerosis, aiming to enable potentially earlier and more precise diagnosis of heart disease. Cleerly's technology strives to provide detailed insights into plaque characteristics, with the goal of supporting personalized treatment plans for patients. This company was founded by James Min MD in 2017 and is headquartered in Denver, CO.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/04/2024 | Series C | $330.08MM | $xx.xx | $729.01MM | Battery Ventures, Breyer Capital, Cigna Ventures, Digitx Partners, Fidelity Management, Heartland Healthcare Capital Funds, Insight Partners, Lrvhealth, Mirae Asset Capital, New Leaf Ventures, Novartis, Peter Thiel, Piper Sandler, Pura Vida Investments, Sands Capital, T. Rowe Price Associates, Vensana Capital | |
Price per Share
$xx.xx
Shares Outstanding
28,019,290
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Battery Ventures, Breyer Capital, Cigna Ventures, Digitx Partners, Fidelity Management, Heartland Healthcare Capital Funds, Insight Partners, Lrvhealth, Mirae Asset Capital, New Leaf Ventures, Novartis, Peter Thiel, Piper Sandler, Pura Vida Investments, Sands Capital, T. Rowe Price Associates, Vensana Capital
|
||||||
06/21/2021 | Series B | $28.1MM | $xx.xx | $114.1MM | Cigna Ventures, Digitx Partners, Lrvhealth, New Leaf Venture Partners, The American College Of Cardiology, Vensana Capital | |
Price per Share
$xx.xx
Shares Outstanding
8,408,926
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cigna Ventures, Digitx Partners, Lrvhealth, New Leaf Venture Partners, The American College Of Cardiology, Vensana Capital
|
||||||
06/21/2021 | Series B-1 | $16.8MM | $xx.xx | $114.1MM | Cigna Ventures, Digitx Partners, Lrvhealth, New Leaf Venture Partners, The American College Of Cardiology, Vensana Capital | |
Price per Share
$xx.xx
Shares Outstanding
3,853,457
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cigna Ventures, Digitx Partners, Lrvhealth, New Leaf Venture Partners, The American College Of Cardiology, Vensana Capital
|
||||||
08/10/2017 | Series A | $11.49MM | $xx.xx | $32.84MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,439,646
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|